-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Passed Our Checks, And It's About To Pay A CN¥0.12 Dividend
Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Passed Our Checks, And It's About To Pay A CN¥0.12 Dividend
Readers hoping to buy Aier Eye Hospital Group Co., Ltd. (SZSE:300015) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is usually set to be one business day before the record date which is the cut-off date on which you must be present on the company's books as a shareholder in order to receive the dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Thus, you can purchase Aier Eye Hospital Group's shares before the 11th of July in order to receive the dividend, which the company will pay on the 11th of July.
The company's next dividend payment will be CN¥0.12 per share, and in the last 12 months, the company paid a total of CN¥0.12 per share. Based on the last year's worth of payments, Aier Eye Hospital Group stock has a trailing yield of around 0.3% on the current share price of CN¥42.51. If you buy this business for its dividend, you should have an idea of whether Aier Eye Hospital Group's dividend is reliable and sustainable. So we need to check whether the dividend payments are covered, and if earnings are growing.
View our latest analysis for Aier Eye Hospital Group
Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Fortunately Aier Eye Hospital Group's payout ratio is modest, at just 26% of profit. A useful secondary check can be to evaluate whether Aier Eye Hospital Group generated enough free cash flow to afford its dividend. It paid out 23% of its free cash flow as dividends last year, which is conservatively low.
It's positive to see that Aier Eye Hospital Group's dividend is covered by both profits and cash flow, since this is generally a sign that the dividend is sustainable, and a lower payout ratio usually suggests a greater margin of safety before the dividend gets cut.
Click here to see the company's payout ratio, plus analyst estimates of its future dividends.
SZSE:300015 Historic Dividend July 7th 2022Have Earnings And Dividends Been Growing?
Stocks in companies that generate sustainable earnings growth often make the best dividend prospects, as it is easier to lift the dividend when earnings are rising. If earnings decline and the company is forced to cut its dividend, investors could watch the value of their investment go up in smoke. That's why it's comforting to see Aier Eye Hospital Group's earnings have been skyrocketing, up 32% per annum for the past five years. Aier Eye Hospital Group is paying out less than half its earnings and cash flow, while simultaneously growing earnings per share at a rapid clip. This is a very favourable combination that can often lead to the dividend multiplying over the long term, if earnings grow and the company pays out a higher percentage of its earnings.
The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. In the past 10 years, Aier Eye Hospital Group has increased its dividend at approximately 24% a year on average. It's exciting to see that both earnings and dividends per share have grown rapidly over the past few years.
The Bottom Line
Has Aier Eye Hospital Group got what it takes to maintain its dividend payments? It's great that Aier Eye Hospital Group is growing earnings per share while simultaneously paying out a low percentage of both its earnings and cash flow. It's disappointing to see the dividend has been cut at least once in the past, but as things stand now, the low payout ratio suggests a conservative approach to dividends, which we like. It's a promising combination that should mark this company worthy of closer attention.
While it's tempting to invest in Aier Eye Hospital Group for the dividends alone, you should always be mindful of the risks involved. For example - Aier Eye Hospital Group has 2 warning signs we think you should be aware of.
A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
希望购买的读者爱尔眼科医院集团有限公司。(SZSE:300015),由于该股即将进行不含股息的交易,其股息将很快采取行动。除息日期通常被设定为记录日期之前的一个工作日,也就是你必须作为股东出现在公司账簿上才能获得股息的截止日期。除息日期很重要,因为股票的任何交易都需要在记录日期之前结算,才有资格获得股息。因此,你可以在7月11日之前购买爱尔眼科医院集团的股票,以便获得股息,该公司将在7月11日支付股息。
公司下一次派息将为每股0.12元人民币,最近12个月,公司共支付每股0.12元人民币。根据去年的支付金额,爱尔眼科医院集团股票的往绩收益率在当前股价42.51元的基础上约为0.3%。如果你为了分红而收购这项业务,你应该对爱尔眼科医院集团的分红是否可靠和可持续有所了解。因此,我们需要检查股息支付是否得到覆盖,以及收益是否在增长。
查看我们对爱尔眼科医院集团的最新分析
股息通常从公司收入中支付,因此,如果一家公司支付的股息超过了它的收入,它的股息通常被削减的风险更高。幸运的是,爱尔眼科医院集团的派息率不高,仅占利润的26%。一个有用的次要检查可以是评估爱尔眼科医院集团是否产生了足够的自由现金流来支付股息。它去年支付了23%的自由现金流作为股息,这是保守的低水平。
看到艾尔眼科医院集团的股息由利润和现金流覆盖,这是积极的,因为这通常是股息可持续的迹象,较低的派息率通常意味着在股息削减之前有更大的安全边际。
点击此处查看该公司的派息率,以及分析师对其未来股息的估计。
深圳证券交易所:300015历史性红利2022年7月7日盈利和股息一直在增长吗?
产生可持续收益增长的公司的股票往往是最好的股息前景,因为当收益上升时,提高股息更容易。如果收益下降,该公司被迫削减股息,投资者可能会眼睁睁地看着他们的投资价值化为乌有。这就是为什么看到艾尔眼科医院集团的收益一直在飙升,在过去五年中以每年32%的速度增长,令人欣慰。AIER眼科医院集团支付的收益和现金流不到一半,同时每股收益快速增长。这是一个非常有利的组合,如果收益增长,公司支付的收益占收益的比例更高,这种组合往往会导致长期股息成倍增长。
大多数投资者评估一家公司的股息前景的主要方式是检查历史上的股息增长率。在过去的10年里,爱尔眼科医院集团平均每年增加约24%的股息。令人兴奋的是,过去几年,每股收益和股息都快速增长。
底线
爱尔眼科医院集团是否获得了维持其股息支付的能力?艾尔眼科医院集团在提高每股收益的同时,支付了收益和现金流的低比例,这是一件很好的事情。看到过去至少削减过一次股息令人失望,但就目前的情况来看,低派息率意味着对股息采取保守的方式,这是我们喜欢的。这是一个很有希望的组合,应该标志着这家公司值得密切关注。
虽然投资爱尔眼科医院集团仅仅是为了分红是很诱人的,但你应该始终注意其中的风险。例如-爱尔眼科医院集团2个警告标志我们认为你应该意识到。
一个常见的投资错误是购买你看到的第一只有趣的股票。在这里你可以找到高收益股息股的完整名单。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧